Safety and Tolerability Study of AAV2-sFLT01 in Patients With Neovascular Age-Related Macular Degeneration (AMD)

Clinical trial NCT01024998 · COMPLETED

Trial details

NCT number: NCT01024998
Sponsor: Genzyme, a Sanofi Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Macular Degeneration Age-Related Maculopathies Age-Related Maculopathy Maculopathies, Age-Related Maculopathy, Age-Related Retinal Degeneration Retinal Neovascularization Gene Therapy Therapy, Gene Eye Diseases

Start date: 2010-01-11
Primary completion: 2014-07-01
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.